{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:37:06Z","timestamp":1792442226730,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ctro.2022.05.004","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T14:14:13Z","timestamp":1652796853000},"page":"70-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5\u00a0cm based on the estimated incidence of hepatic toxicity"],"prefix":"10.1016","volume":"35","author":[{"given":"Yusuke","family":"Uchinami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kanehira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishin","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeko","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuki","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctro.2022.05.004_b0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamaoncol.2017.2303","article-title":"Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial","volume":"4","author":"Feng","year":"2018","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2022.05.004_b0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/hepr.12916","article-title":"Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma","volume":"48","author":"Teraoka","year":"2018","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.ctro.2022.05.004_b0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4340-7","article-title":"Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma","volume":"18","author":"Jeong","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2022.05.004_b0020","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1186\/s12885-019-6063-9","article-title":"Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (\u22645 cm)","volume":"19","author":"Sun","year":"2019","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.ctro.2022.05.004_b0025","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/hepr.13649","article-title":"Treatment outcomes of stereotactic body radiation therapy using a real-time tumor-tracking radiotherapy system for hepatocellular carcinomas","volume":"51","author":"Uchinami","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ctro.2022.05.004_b0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2018.10.041","article-title":"Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma","volume":"133","author":"Chadha","year":"2019","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.05.004_b0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-020-01605-4","article-title":"Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis","volume":"15","author":"Cheng","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2022.05.004_b0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2019.01.076","article-title":"Protons vs Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival Proton Radiotherapy for Hepatocellular Carcinoma","volume":"105","author":"Sanford","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2022.05.004_b0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.21037\/jgo.2019.08.03","article-title":"Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation","volume":"10","author":"Hasan","year":"2019","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2022.05.004_b0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semradonc.2017.11.008","article-title":"Clinical Trial Strategies to Compare Protons With Photons","volume":"28","author":"Langendijk","year":"2018","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.05.004_b0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2015.10.004","article-title":"The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine","volume":"95","author":"Widder","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2022.05.004_b0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2022.05.004_b0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.radonc.2020.02.022","article-title":"Perspectives on the model-based approach to proton therapy trials: A retrospective study of a lung cancer randomized trial","volume":"147","author":"McNamara","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2022.05.004_b0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.radonc.2021.04.008","article-title":"Identification of patient benefit from proton beam therapy in brain tumour patients based on dosimetric and NTCP analyses","volume":"160","author":"Dutz","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.05.004_b0075","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-8-48","article-title":"What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy","volume":"8","author":"Toramatsu","year":"2013","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.ctro.2022.05.004_b0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13014-018-1151-6","article-title":"Estimation of the risk for radiation-induced liver disease following photon- or proton-beam radiosurgery of liver metastases","volume":"13","author":"Mondlane","year":"2018","journal-title":"Radiation Oncology"},{"issue":"4","key":"10.1016\/j.ctro.2022.05.004_b0085","doi-asserted-by":"crossref","first-page":"e94971","DOI":"10.1371\/journal.pone.0094971","article-title":"A proton beam therapy system dedicated to spot-scanning increases accuracy with moving tumors by real-time imaging and gating and reduces equipment size","volume":"9","author":"Shimizu","year":"2014","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ctro.2022.05.004_b0090","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ijrobp.2018.05.063","article-title":"Automated instead of manual treatment planning? A plan comparison based on dose-volume statistics and clinical preference","volume":"102","author":"Vanderstraeten","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2022.05.004_b0095","doi-asserted-by":"crossref","unstructured":"McConnell KA, Marston T, Zehren BE, Lirani A, Stanley DN, Bishop A, et al. Dosimetric Evaluation of Pinnacle's Automated Treatment Planning Software to Manually Planned Treatments. Technol Cancer Res Treat. 2018;17:1533033818780064.","DOI":"10.1177\/1533033818780064"},{"key":"10.1016\/j.ctro.2022.05.004_b0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejmp.2018.01.016","article-title":"Evaluation of a commercial automatic treatment planning system for liver stereotactic body radiation therapy treatments","volume":"46","author":"Gallio","year":"2018","journal-title":"Physica Med"},{"issue":"1","key":"10.1016\/j.ctro.2022.05.004_b0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/acm2.12219","article-title":"A knowledge-based approach to automated planning for hepatocellular carcinoma","volume":"19","author":"Zhang","year":"2018","journal-title":"J Appl Clin Med Phys"},{"issue":"4","key":"10.1016\/j.ctro.2022.05.004_b0110","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Radiat Oncol Biol"},{"issue":"5","key":"10.1016\/j.ctro.2022.05.004_b0115","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2004.05.048","article-title":"Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease","volume":"60","author":"Cheng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2022.05.004_b0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijrobp.2005.11.034","article-title":"Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma","volume":"65","author":"Xu","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2022.05.004_b0125","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2020.04.027","article-title":"Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation","volume":"107","author":"Pursley","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2022.05.004_b0130","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/bjd.17126","article-title":"Lack of confidence interval reporting in dermatology: a call to action","volume":"180","author":"Hopkins","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ctro.2022.05.004_b0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.radonc.2020.07.056","article-title":"First experience with model-based selection of head and neck cancer patients for proton therapy","volume":"151","author":"Tambas","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2022.05.004_b0140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2019.08.005","article-title":"Practical robustness evaluation in radiotherapy \u2013 A photon and proton-proof alternative to PTV-based plan evaluation","volume":"141","author":"Korevaar","year":"2019","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2022.05.004_b0145","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.rpor.2020.03.012","article-title":"Characterization of robust optimization for VMAT plan for liver cancer","volume":"25","author":"Miura","year":"2020","journal-title":"Rep Pract Oncol Radiother"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630822000416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630822000416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:09:55Z","timestamp":1762502995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630822000416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":29,"alternative-id":["S2405630822000416"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2022.05.004","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5\u00a0cm based on the estimated incidence of hepatic toxicity","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2022.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}